Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis.

Macha TetartFrederic WalletMaeva KyhengSylvie LeroyThierry PerezOlivier Le RouzicBenoit WallaertAnne Prevotat

Published in: ERJ open research (2019)

A. xylosoxidans isolation is associated with a decline in respiratory function in patients with CF. Chronic A. xylosoxidans isolation and P. aeruginosa co-isolation may be markers of more severe respiratory disease in Ax+ patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
cystic fibrosis
prognostic factors
peritoneal dialysis
early onset
patient reported